ATE454630T1 - Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers - Google Patents
Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpersInfo
- Publication number
- ATE454630T1 ATE454630T1 AT06016296T AT06016296T ATE454630T1 AT E454630 T1 ATE454630 T1 AT E454630T1 AT 06016296 T AT06016296 T AT 06016296T AT 06016296 T AT06016296 T AT 06016296T AT E454630 T1 ATE454630 T1 AT E454630T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor antibody
- diagnosing
- receptor
- disease involving
- disease
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000027932 Collagen disease Diseases 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- 206010047115 Vasculitis Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000002616 plasmapheresis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Rehabilitation Therapy (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06016296A EP1884775B1 (de) | 2006-08-04 | 2006-08-04 | Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-Antikörpers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE454630T1 true ATE454630T1 (de) | 2010-01-15 |
Family
ID=37401029
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06016296T ATE454630T1 (de) | 2006-08-04 | 2006-08-04 | Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers |
| AT07802440T ATE518139T1 (de) | 2006-08-04 | 2007-07-31 | Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07802440T ATE518139T1 (de) | 2006-08-04 | 2007-07-31 | Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8425877B2 (de) |
| EP (2) | EP1884775B1 (de) |
| AT (2) | ATE454630T1 (de) |
| DE (1) | DE602006011602D1 (de) |
| ES (2) | ES2336350T3 (de) |
| PL (2) | PL1884775T3 (de) |
| WO (1) | WO2008015218A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10123929A1 (de) | 2001-05-11 | 2002-11-21 | Celltrend Gmbh | Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit |
| EP1884776A1 (de) * | 2006-08-04 | 2008-02-06 | Celltrend GmbH | Verfahren zur diagnose einer krankheit, die auf der gegenwart des anti-endothelin-antikörpers beruht |
| ATE454630T1 (de) | 2006-08-04 | 2010-01-15 | Celltrend Gmbh | Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers |
| BR112012026006A2 (pt) | 2010-04-12 | 2019-09-24 | Cell Trend GmbH | método para diagnose de esclerose múltipla envolvendo anticorpo antirreceptor at1 |
| US8483415B2 (en) | 2010-06-18 | 2013-07-09 | Motorola Mobility Llc | Antenna system with parasitic element for hearing aid compliant electromagnetic emission |
| US20170082619A1 (en) | 2015-09-23 | 2017-03-23 | One Lambda, Inc. | Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens |
| US10648977B2 (en) | 2015-10-30 | 2020-05-12 | The Johns Hopkins University | Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers |
| WO2017123550A1 (en) * | 2016-01-11 | 2017-07-20 | Autotelic Llc | Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension |
| CN108948183B (zh) * | 2018-06-05 | 2022-01-28 | 武汉华纪元生物技术开发有限公司 | α1受体和AT1受体抗原类似物多肽及其抗体检测试剂盒和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2866182B2 (ja) | 1990-10-08 | 1999-03-08 | 日本ケミファ株式会社 | エンドセリン受容体 |
| FR2787330A1 (fr) | 1998-12-18 | 2000-06-23 | Sanofi Sa | Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe |
| DE19954305A1 (de) * | 1998-12-24 | 2000-06-29 | Max Delbrueck Centrum | Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie |
| CA2363999A1 (en) | 1998-12-24 | 2000-07-06 | Max-Delbruck-Centrum Fur Molekulare Medizin | Peptides of the at1 receptor and their use for preeclampsia and malign hypertension |
| CA2314811A1 (en) * | 2000-08-02 | 2002-02-02 | Brian Archibald Macvicar | Autoimmunity to angiotensin at1 receptors in schizophrenia |
| DE10123929A1 (de) | 2001-05-11 | 2002-11-21 | Celltrend Gmbh | Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit |
| US20030078190A1 (en) * | 2001-05-25 | 2003-04-24 | Weinberg Marc S. | Methods for tissue protection using highly effective inhibition of the renin-angiotensin system |
| AU2003293004A1 (en) | 2002-11-29 | 2004-06-23 | Max-Delbruck-Centrum Fur Molekulare Medizin | Identification of agonistic autoantibodies |
| US20060135422A1 (en) | 2003-04-17 | 2006-06-22 | Moskowitz David W | Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
| WO2006060336A2 (en) | 2004-11-30 | 2006-06-08 | The Johns Hopkins University | Endothelin-2 and retinal damage |
| EP1884776A1 (de) | 2006-08-04 | 2008-02-06 | Celltrend GmbH | Verfahren zur diagnose einer krankheit, die auf der gegenwart des anti-endothelin-antikörpers beruht |
| ATE454630T1 (de) | 2006-08-04 | 2010-01-15 | Celltrend Gmbh | Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers |
-
2006
- 2006-08-04 AT AT06016296T patent/ATE454630T1/de not_active IP Right Cessation
- 2006-08-04 DE DE602006011602T patent/DE602006011602D1/de active Active
- 2006-08-04 PL PL06016296T patent/PL1884775T3/pl unknown
- 2006-08-04 EP EP06016296A patent/EP1884775B1/de active Active
- 2006-08-04 ES ES06016296T patent/ES2336350T3/es active Active
-
2007
- 2007-07-31 EP EP07802440A patent/EP2057467B1/de active Active
- 2007-07-31 WO PCT/EP2007/057910 patent/WO2008015218A2/en not_active Ceased
- 2007-07-31 AT AT07802440T patent/ATE518139T1/de active
- 2007-07-31 ES ES07802440T patent/ES2369798T3/es active Active
- 2007-07-31 PL PL07802440T patent/PL2057467T3/pl unknown
- 2007-07-31 US US12/376,164 patent/US8425877B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100098688A1 (en) | 2010-04-22 |
| EP2057467A2 (de) | 2009-05-13 |
| WO2008015218A2 (en) | 2008-02-07 |
| US8425877B2 (en) | 2013-04-23 |
| PL1884775T3 (pl) | 2010-06-30 |
| WO2008015218A3 (en) | 2008-07-03 |
| EP1884775B1 (de) | 2010-01-06 |
| ATE518139T1 (de) | 2011-08-15 |
| PL2057467T3 (pl) | 2011-12-30 |
| EP2057467B1 (de) | 2011-07-27 |
| EP1884775A1 (de) | 2008-02-06 |
| DE602006011602D1 (de) | 2010-02-25 |
| ES2336350T3 (es) | 2010-04-12 |
| ES2369798T3 (es) | 2011-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE518139T1 (de) | Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers | |
| ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
| ATE456055T1 (de) | Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden | |
| ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
| ATE550658T1 (de) | Verfahren für den nachweis oder die diagnose neurodegenerativer erkrankungen oder leiden | |
| BRPI0707645B8 (pt) | métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano | |
| GB2488700B (en) | Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual | |
| EP1930426A4 (de) | Zusammensetzung und verfahren zur diagnose von nierenkrebs und abschätzung der prognose eines nierenkrebspatienten | |
| EP1810026A4 (de) | B7-h1 und verfahren zur diagnose, prognose und behandlung von krebs | |
| EP2074582A4 (de) | System und verfahren zur erleichterung von automatisierten zahnmedizinischen messungen und diagnosen | |
| AR086734A1 (es) | Metodos de diagnostico de la enfermedad tromboembolica | |
| NZ594772A (en) | Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c | |
| NZ600160A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP2319924A4 (de) | Polypeptidmarker zur diagnose von arteriosklerose, verfahren für den nachweis von arteriosklerose anhand des markers oder dergleichen und kit für die diagnose von arteriosklerose | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| CY1122202T1 (el) | Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης | |
| EP1977234A4 (de) | Moleküle zur behandlung von lungenerkrankungen mit einer immunreaktion mit verbindungsgewebe in der lunge | |
| ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
| RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
| ATE528651T1 (de) | Diagnoseverfahren für pulmonale arterielle hypertonie | |
| DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| EP2167683A4 (de) | Verfahren zur vorhersage oder diagnose einer magen-darm-störung oder -krankheit | |
| CY1111602T1 (el) | ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ | |
| RU2009146803A (ru) | Способ диагностики деструктивного панкреатита | |
| BR112013030646A2 (pt) | uso diagnóstico de pró-somatostatina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |